UCI MEDICAL AFFILIATES INC
NT 10-K, 2000-12-29
SPECIALTY OUTPATIENT FACILITIES, NEC
Previous: WATCHOUT INC, S-8, EX-10.3, 2000-12-29
Next: VAN KAMPEN U S GOVERNMENT TRUST, 497, 2000-12-29




                    FORM 12b-25 NOTIFICATION OF LATE FILING

                                                       SEC FILE NUMBER
                                                       0-13265
                                                       CUSIP NUMBER
                                                       902633 10 6
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 (Check One):    X  Form 10-K     Form 20-F   Form 11-K
Form 10-Q       Form N-SAR
For Period Ended: __September 30, 2000
[  ] Transition Report on Form 10-K
[  ] Transition Report on Form 20-F
[  ] Transition Report on Form 11-K
[  ] Transition Report on Form 10-Q
[  ] Transition Report on Form N-SAR
For the Transition Period Ended: __________________________
Read Instruction (on back page) Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commissions has
verified any information contained herein.

     If the  notification  relates  to a portion of the  filing  checked  above,
identify the item(s) to which the notification relates:
______________________________________________________________________________


PART 1  REGISTRANT INFORMATION (Official Text)
UCI Medical Affiliates, Inc.
Full Name of Registrant:
_______________________
Former Name if Applicable

1901 Main Street, Suite 1200, Mail Code 1105
Address of Principal Executive Office (Street and Number)

Columbia, South Carolina  29201
City, State and Zip Code

PART I  Rules 12b-25(b) AND (c) (Official Text)
     If the subject  report could not be filed  without  unreasonable  effort or
expense  and  the  registrant  seeks  relief  pursuant  to Rule  12b-25(b),  the
following should be completed. (Check box if appropriate)
     ( X ) (a) The reasons  described in  reasonable  detail in Part III of this
form could not be eliminated without unreasonable effort or expense;
     ( X ) (b) The subject annual report,  semi-annual report, transition report
on Form 10-K, Form 20-F, 11-K, Form N-SAR, or portion thereof,  will be filed on
or before the fifteenth  calendar day following the  prescribed due date; or the
subject  quarterly report of transition  report on Form 10-Q, or portion thereof
will be filed on or before the fifth  calendar day following the  prescribed due
date; and
     ( ) (c) The  accountant's  statement  or  other  exhibit  required  by Rule
12b-25(c) has been attached if applicable.

PART III  NARRATIVE (Official Text)
     State below in reasonable detail the reasons why the Form 10-K, 11-K, 10-Q,
N-SAR, or the transition  report or portion  thereof,  could not be filed within
the prescribed time period. (Attach Extra Sheets if Needed)

     The filing of Form 10-K by UCI Medical Affiliates,  Inc., is delayed as the
result of unforeseen  difficulties  in the  completion  of the Company's  annual
audit by PricewaterhouseCoopers, LLP for the year ended September 30, 2000.

     The Company has recorded  several  significant  transactions  in the second
half of its fiscal  year  related  to the  closing  of its  centers in  Atlanta,
Georgia. This has placed additional burden on the Company's accounting personnel
which required the Company to delay the start of its audit and necessitates this
extension.

     The  delay in this  filing of Form 10-K  could  not be  eliminated  without
unreasonable effort or expense.


PART IV  OTHER INFORMATION (Official Text)
     (1) Name and  telephone  number  of  person  to  contact  in regard to this
notification

Jerry F. Wells, Jr., CPA, EVP of Finance and CFO             (803) 252-3661
         (Name)                               (Area Code) (Telephone Number)
     (2) Have all other periodic  reports  required under Section 13 or 15(d) of
the Securities  Exchange Act of 1934 or Section 30 of the Investment Company Act
of 1940  during the  preceding  12 months or for such  shorter  period  that the
registrant  was  required to file such  report(s)  been filed?  If answer is no,
identify report(s). ( X) Yes  (   )No

     (3) Is it anticipated that any significant  change in results of operations
from the corresponding  period for the last fiscal year will be reflected by the
earnings  statement to be included in the subject report or portion thereof?
(X) Yes ( ) No

     If so, explain the anticipated change, both narratively and quantitatively,
and, if appropriate,  state the reasons why a reasonable estimate of the results
cannot be made.

     The Company  closed its operating  centers in the Atlanta,  Georgia  market
effective June 30, 2000. As a result of this decision,  the Company  recorded an
impairment in the quarter ended March 31, 2000 of $3,567,000 to reduce goodwill.
Additional costs relating to lease obligations and severance are estimated to be
approximately $490,000.

         UCI Medical Affiliates, Inc.
(Name of Registrant as Specified in Charter)

     has caused this  notification to be signed on its behalf by the undersigned
hereunto duly authorized.

Date:    December 29, 2000           By: /s/ Jerry F. Wells, Jr., CPA
                                        Jerry F. Wells, Jr., CPA
                                        Executive Vice President of Finance
                                        and Chief Financial Officer

     INSTRUCTION:  The  form  may  be  signed  by an  executive  officer  of the
registrant or by any other duly authorized representative. The name and title of
the person signing the form shall be typed or printed beneath the signature.  If
the  statement  is  signed  on  behalf  of  the   registrant  by  an  authorized
representative   (other   than   an   executive   officer),   evidence   of  the
representative's  authority to sign on behalf of the  registrant  shall be filed
with the form.

ATTENTION
     Intentional  misstatements or omissions of fact constitute Federal Criminal
Violations (See 18 U.S.C. 1001).




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission